towards nucleosides and glycoproteins, as well as high binding
capacity. This boronate affinity monolith could function at
pH as low as pH 5.0, which is the lowest among all boronate
affinity chromatographic columns reported in the literature.
The feasibility of application to real complex samples was
demonstrated with the selective enrichment of urinary nucleosides.
Furthermore, the boronate affinity monolith exhibited apparent
secondary separation capability towards nucleosides under acidic
elution conditions, which may provide a new opportunity for the
development of LC techniques for the separation of nucleosides
and other cis-diol containing compounds.
Fig. 3 Specific capture of glycoproteins on the modified column and
comparison with non-glycoproteins. Mobile phase, 20 mM HEPES
We gratefully acknowledge the financial support from
the National Natural Science Foundation of China (Grants
No. 21075063 and 21121091), the Natural Science Foundation
of Jiangsu Province (Grant No. KB2011054), the Ministry
of Science and Technology of China (Grant No. 34-8) and
Dionex China.
2
containing 100 mM MgCl (pH 7.0), switching to 100 mM HOAc (pH 2.7)
ꢀ1
at 15 min; samples (a–h) 1 mg mL responding proteins dissolved in
loading buffer, (i) the loading buffer as blank control; detection at 214 nm.
The proteins used: (a) RNase B, (b) HRP, (c) anti-AFP monoclonal
antibody, (d) anti-CEA polyclonal antibody, (e) anti-PSA monoclonal
antibody; (f) RNase A, (g) cytochrome C, (h) b-lactoglobin.
Notes and references
1
T. D. James, K. R. A. S. Sandanayake and S. Shinkai, Angew.
Chem., Int. Ed., 1996, 35, 1910–1922.
2
(a) R. P. Singhal, B. Ramamurthy, N. Gvindraj and Y. Sarwar,
J. Chromatogr., 1991, 543, 17–38; (b) X. C. Liu and W. H. Scouten,
J. Chromatogr., A, 1997, 687, 61–69.
3
4
(a) A. J. Sasco, F. Rey, C. Reynaud, J. Y. Bobin, M. Clavel and
A. Niveleau, Cancer Lett., 1996, 108, 157–162; (b) B. S. Vold,
L. E. Kraus, V. G. Rimer and R. C. Coombes, Cancer. Res., 1986,
4
6, 3164–3167; (c) G. W. Xu, H. R. Schmid, X. Lu, H. M. Liebich
and P. Lu, Biomed. Chromatogr., 2000, 4, 1–5.
(a) J. H. Lee, Y. S. Kim, M. Y. Ha, E. K. Lee and J. B. Choo,
J. Am. Soc. Mass Spectrom., 2005, 16, 1456–1460; (b) Y. W. Xu,
Z. X. Wu, L. J. Zhang, H. J. Lu, P. Y. Yang, P. A. Webley and
D. Y. Zhao, Anal. Chem., 2009, 81, 503–508; (c) J. Tang, Y. C. Liu,
D. W. Qi, G. P. Yao, C. H. Deng and X. M. Zhang, Proteomics,
2009, 9, 5046–5055; (d) L. J. Zhang, Y. W. Xu, H. L. Yao,
L. Q. Xie, J. Yao, H. J. Lu and P. Y. Yang, Chem.–Eur. J.,
Fig. 4 The electropherograms of male urine samples analyzed by MEKC.
0
Urine sample: (b) un-extracted and (b ) extracted by the functionalized
monolithic column under neutral conditions. Peaks identity: 1, uridine;
3
, cytidine; 4, xanthosine; 5, adenosine or guanosine; 7, inosine.
2
2009, 81, 6474–6480.
(a) S. Hjerten, Y. M. Li, J. L. Liao, J. Mohammad, K. Nakazato
and G. Pettersson, Nature, 1992, 356, 810–811; (b) F. Svec and
J. M. J. Frechet, Science, 1996, 273, 205–211.
009, 15, 10158–10166; (e) Y. Q. Jiang and Y. F. Ma, Anal. Chem.,
of the selective enrichment of nucleosides from two human urine
samples (from a male and a female healthy adult respectively)
under physiological conditions. The extracted and un-extracted
samples were analyzed by micellar electrokinetic chromatography
5
6 (a) O. G. Potter, M. C. Breadmore and E. F. Hilder, Analyst, 2006,
31, 1094–1096; (b) L. B. Ren, Z. Liu, M. M. Dong, M. L. Ye and
H. F. Zou, J. Chromatogr., A, 2009, 1216, 4768–4774;
c) L. B. Ren, Z. Liu, Y. C. Liu, P. Dou and H. Y. Chen, Angew.
1
(MEKC). The results verified the excellent selectivity and affinity
of the functionalized monolith towards nucleosides in the urine
matrices, and the BA-based extraction allowed for close-up
examination of the profile of target molecules (Fig. S10 and S11
in the ESIw). As an example, the close-up profiles for extracted
and un-extracted male urine are shown in Fig. 4. Through the
boronate affinity extraction, some components (peaks 2, 9, 12, 13,
(
Chem., Int. Ed., 2009, 48, 6704–6707; (d) L. B. Ren, Y. C. Liu,
M. M. Dong and Z. Liu, J. Chromatogr., A, 2009, 1216,
8
421–8435; (e) M. Chen, Y. Lu, Q. Ma, L. Guo and Y. Q. Feng,
Analyst, 2009, 134, 2158–2164; (f) Y. C. Liu, L. B. Ren and Z. Liu,
Chem. Commun., 2011, 47, 5067–5069; (g) H. Y. Li, Y. C. Liu,
J. Liu and Z. Liu, Chem. Commun., 2011, 47, 8169–8172;
(h) Z. A. Lin, J. L. Pang, H. H. Yang, Z. W. Cai, L. Zhang and
G. N. Chen, Chem. Commun., 2011, 47, 9675–9678.
G. Wulff, Pure Appl. Chem., 1982, 54, 2093–2102.
(a) M. Dowlut and D. G. Hall, J. Am. Chem. Soc., 2006, 128,
4226–4227; (b) M. Berube, M. Dowlut and D. G. Hall, J. Org.
Chem., 2008, 73, 6471–6479; (c) S. Schumacher and M. Katterle,
et al., Chem. Sens., 2011, 1, 1–7; (d) S. Schumacher and M. Katterle,
et al., J. Mol. Recognit., 2011, 24, 953–959; (e) A. Pal, M. Berube
and D. G. Hall, Angew. Chem., Int. Ed., 2010, 49, 1492–1495.
J. I. Jay and B. E. Lai, et al., Mol. Pharmaceutics, 2009, 7, 116–129.
1
4, 15, 17 and 21) in original urine were completely removed while
other components (peaks 1, 3, 4, 5, 6, 7, 8, 10, 11, 16, 19 and 20)
were effectively enriched. Especially, some components (peaks 1,
7
8
3
, 16 and 19) could not be observed if the sample was not
extracted by the monolithic column. While, after extraction,
they were clearly observed. The identities of some of the peaks
(1, uridine; 3, cytidine; 4, xanthosine; 5, adenosine or guanosine;
9
1
7, inosine) confirmed the excellent specificity of the functionalized
0 C. Z. Ding and Y. K. Zhang, et al., Bioorg. Med. Chem. Lett.,
010, 20, 7317–7322.
1 Y. Kawachi, T. Ikegami, H. Takubo, Y. Ikegami, M. Miyamoto
monolithic column towards urinary nucleosides.
2
The benzoboroxole-functionalized monolithic column synthe-
sized in this work exhibited excellent selectivity and affinity
1
and N. Tanaka, J. Chromatogr., A, 2011, 1218, 5903–5919.
This journal is c The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 4115–4117 4117